Megan Pendleton

Megan was previously a member of the Firm’s Public Company Advisory Group where she advised U.S. public companies, foreign private issuers, boards of directors, special committees, executives and private equity sponsors on a full range of corporate governance and compliance matters.

Experience

• The Dow Chemical Company in its $130 billion all-stock merger of equals with E. I. du Pont de Nemours and Company
• Dow in its approximately $40 billion spin-off from DowDuPont Inc. as part of DowDuPont's separation into three independent, publicly traded companies, one each for its agriculture, materials science and specialty products businesses
• The Kroger Company in its proposed $24.6 billion merger with Albertsons Companies, Inc.
• The Kroger Company, along with The Albertsons Companies, Inc., in the approximately $1.9 billion sale of 413 stores, as well as select banners, distribution centers, offices and private label brands, to C&S Wholesale Grocers, LLC in connection with Kroger’s proposed merger with Albertsons Companies Inc.
• Sanofi in its $20.1 billion acquisition of Genzyme Corporation
• GE in the $18.1 billion sale of NBCUniversal and related real estate to Comcast
• Willis Group Holdings plc in its $18 billion merger of equals with Towers Watson & Co.
• Churchill Capital Corp III, a SPAC sponsored by Churchill Capital Group, in its $5.7 billion merger with MultiPlan, Inc. that has an enterprise value based on the transaction of approximately $11 billion
• NEOGEN Corporation in its $5.3 billion combination with the Food Safety business of 3M, in a Reverse Morris Trust transaction that implied an enterprise value of the combined company of $9.3 billion
• Foley Trasimene Acquisition Corp. II, a SPAC sponsored by an affiliate of Trasimene Capital Management, LLC and led by William P. Foley II, in a $9 billion business combination with Paysafe Limited
• Apergy Corporation (n/k/a ChampionX Corporation) in a Reverse Morris Trust acquisition of ChampionX (f/k/a Nalco Champion) from Ecolab Inc. creating an entity with a combined $7.4 billion enterprise value
• Foley Trasimene Acquisition Corp., a SPAC sponsored by Bilcar FT, LP and Trasimene Capital FT, LP., in its $7.3 billion combination with Alight Solutions LLC
• Vonage Holdings Corp. in its $6.2 billion sale to Telefonaktiebolaget LM Ericsson
• Eli Lilly and Company in its $5.4 billion acquisition of the animal health business of Novartis AG and in the acquisition by Elanco, its animal health division, of Lohmann SE
• Covetrus, Inc. in its $4 billion sale to CD&R, a holder of approximately 24% of Covetrus' outstanding common stock, and TPG
• Fidelity National Financial, Inc. in its $2.9 billion acquisition of Lender Processing Services, Inc. (n/k/a Black Knight, Inc.)
• GS Acquisition Holdings Corp II, a SPAC sponsored by an affiliate of Goldman Sachs, in its $2.6 billion business combination with Mirion Technologies, Inc. (at the time, a portfolio company of Charterhouse Capital Partners)
• Front Yard Residential Corporation in its $2.5 billion take-private by a partnership formed by Pretium Partners and Ares Management
• MGM Resorts International in its formation of MGM Growth Properties LLC (MGP) and on the corporate aspects of MGP’s $1.05 billion initial public offering
• Iron Mountain Incorporated in its acquisition of ITRenew, Inc., in a transaction that implied an ITRenew enterprise value of $925 million
• Cannae Holdings, Inc. in its creation of an external management structure and entry into a management services agreement with Trasimene Capital Management, LLC
• Citadel Broadcasting in its $2.4 billion sale to Cumulus Media
• Genesis Lease Limited in its $1.75 billion sale to AerCap Holdings N.V.
• Man Group plc in its $1.6 billion acquisition of GLG Partners, Inc.
• Jazz Pharmaceuticals plc in its $1 billion acquisition of Gentium S.p.A.
• Whirlpool Corporation in its $1 billion modified Dutch auction tender offer for its common stock
• CA Technologies in its $200 million acquisition of Arcot Systems
• DaVita Healthcare Partners Inc. in its acquisition of European dialysis centers from Fresenius Medical Care

Megan has been recognized as a 2022 “Rising Star” for Mergers & Acquisitions by Expert Guides and as a “Rising Star” for Corporate by Super Lawyers since 2017. She is recognized as a “Rising Star” for M&A in the U.S. by IFLR1000.